Outline
• Background: Molecular imaging in drug development • Methods: • Outlook: Improved drug design to minimize the formation of radical metabolites
Molecular imaging in drug development
• Assessment of biological and biochemical processes in living subjects
• Earlier detection and characterization of disease, and evaluation of treatment
• Repetitive, non-invasive and uniform studies of the same living subject using identical or alternative biological imaging assays at different time points reducing the number of
Importance of ROS imaging
Reactive oxygen species (ROS) operate as signaling molecules under various physiological conditions, and overproduction of ROS is involved in the pathogenesis of many diseases.
Fluorescent probes for visualizing ROS are promising tools with which to uncover the molecular mechanisms of physiological and pathological processes and might also be useful for diagnosis.
1.Imaging of H 2 O 2 with chemiluminescent nanoparticles (CRET)
Lee et al. Nat. Mater. 2007
Peroxalate nanoparticles properties: 
Semiconducting polymer nanoparticles (SPNs)
• New class of photostable fluorescent nanomaterials with excellent brightness (orders of magnitude higher than that of small-molecule fluorophores, and tens of times better than that of QDs)
• Composed of p-conjugated polymers, their use as fluorescent probes eliminates the possibility of heavy metal ion-induced toxicity to living organisms  good biocompatibility 
Preparation of the Nanoprobe

Nanodrone to detect RONS in cells
Bacterial cell wall lipopolysaccharide (LPS) and phorbol 12-myristate 13-acetate (PMA) to elicit the elevated production of RONS such as ONOO and ClO
In vivo imaging of RONS with NanoDRONE in a LPS-induced acute peritonitis mouse model Summary SPN-based NIR nanoprobe:
• combines RONS inert property of SPN with a RONS sensitive cyanine derivative for imaging of RONS • presents high physiological stability, good biodistribution, long circulation half-life, and passive targeting to inflammatory regions This nanoprobe allows for detection of RONS in the microenvironment of inflammation using systemic administration.
Disadvantage: the current probe does not show specificity over ONOO -, ClO -, . OH and, and is more suitable for detection of the RONS pool at inflammation sites in living animals.
Background
• Drug-induced hepatotoxicity is also the single most important cause of both US Food and Drug Administration (FDA) nonapproval of drugs and withdrawal of drugs from the market after approval  innovative preclinical hepatotoxicity screening methods to reduce hepatotoxicity during drug development • In the liver, drugs undergo enzymatic biotransformation, which enhances metabolite hydrophilicity and clearance from the body. However, biotransformation can also generate reactive radicals or reactive electrophiles through one-or two-electron oxidation reactions
Goal: Develop and implement methods to detect radical species (ROS, RNS) for preclinical drug-safety screening (direct evaluation of acute hepatotoxicity)
Method: nanosensor for rapid, simultaneous and differential detection of RNS and ROS using two optically independent channels by combining fluorescence resonance energy transfer (FRET) and chemiluminescence resonance energy transfer (CRET)  CF-SPN (CRET-FRET semiconducting polymer nanoparticles)
